HV-101
/ Hervor Therap, TCRCure
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 04, 2024
HV-101 for Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=18 | Recruiting | Sponsor: Hervor Therapeutics | Phase classification: P1/2 ➔ P1
Metastases • Phase classification • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1